Yang Qihao, Wu Jianqun, Huang Songqiang, Zeng Jing, Jing Yihan, Wang Zhiyong, Zhang Chi, Wu Zenghui, Liu Song, Wang Zhao
Department of Orthopaedic Surgery, Guangzhou Key laboratory of Spine Disease Prevention and Treatment, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Department of Pain, Hubei No. 3 People's Hospital of Jianghan University, Wuhan, China.
Exp Mol Med. 2025 Sep 1. doi: 10.1038/s12276-025-01529-7.
Here we investigate the effects and mechanisms of eicosapentaenoic acid (EPA) in regulating chondrocyte mechanics during inflammation in the progression of osteoarthritis (OA). Primary porcine chondrocytes and human OA chondrocytes were isolated and cultured. Cell mechanical properties were measured using atomic force microscopy. RNA sequencing, immunocytochemistry, quantitative PCR and western blotting were used to elucidate associated signaling mechanisms. Porcine cartilage and human OA cartilage explants were collected. Human articular cartilage samples were obtained from ten donors. Anterior cruciate ligament transection surgery was performed to induce OA in male C57BL/6J mice. The therapeutic effects of EPA and activation of associated signaling were evaluated using histology, immunohistochemistry and micro-computed tomography. EPA reduced F-actin intensity and Young's modulus in IL-1α-treated porcine chondrocytes and in human OA chondrocytes. Mechanistically, EPA inhibited IL-1α-induced increase in CD44 expression in porcine chondrocytes by suppressing phosphorylation of NF-κB subunits p65. In addition, EPA alleviated articular cartilage degeneration and decreased the expression of p-p65 and CD44 in IL-1α-treated porcine and human OA cartilage explants. Moreover, EPA suppressed the increase in Young's modulus induced by CD44 ligands (A6 peptide and low-molecular-weight hyaluronic acid) in porcine chondrocytes. Finally, intraarticular injection of EPA emulsion-integrated hyaluronic acid injection attenuated OA-associated alterations in articular cartilage and subchondral bone and decreased CD44 expression in mice. Our data not only provide new insights into EPA's chondroprotective actions and underlying mechanisms but also offer new evidence supporting the therapeutic efficacy of a novel EPA emulsion-integrated hyaluronic acid injection for OA treatment.
在此,我们研究了二十碳五烯酸(EPA)在骨关节炎(OA)进展过程中炎症期间调节软骨细胞力学的作用及机制。分离并培养了原代猪软骨细胞和人OA软骨细胞。使用原子力显微镜测量细胞力学特性。采用RNA测序、免疫细胞化学、定量PCR和蛋白质印迹法阐明相关信号机制。收集了猪软骨和人OA软骨外植体。从10名供体获取人关节软骨样本。对雄性C57BL/6J小鼠进行前交叉韧带横断手术以诱导OA。使用组织学、免疫组织化学和微计算机断层扫描评估EPA的治疗效果以及相关信号的激活情况。EPA降低了白细胞介素-1α(IL-1α)处理的猪软骨细胞和人OA软骨细胞中的F-肌动蛋白强度和杨氏模量。机制上,EPA通过抑制核因子κB(NF-κB)亚基p65的磷酸化,抑制IL-1α诱导的猪软骨细胞中CD44表达的增加。此外,EPA减轻了IL-1α处理的猪和人OA软骨外植体中的关节软骨退变,并降低了p-p65和CD44的表达。此外,EPA抑制了猪软骨细胞中CD44配体(A6肽和低分子量透明质酸)诱导的杨氏模量增加。最后,关节内注射EPA乳液联合透明质酸注射减轻了小鼠关节软骨和软骨下骨中与OA相关的改变,并降低了CD44的表达。我们的数据不仅为EPA的软骨保护作用及其潜在机制提供了新的见解,还为新型EPA乳液联合透明质酸注射治疗OA的疗效提供了新的证据。